UPLOAD Filing
ADC Therapeutics SA
Date: March 12, 2026 · CIK: 0001771910 · Accession: 0000000000-26-002553
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-294191
Letter
March 12, 2026 Ameet Mallik Chief Executive Officer and Director ADC Therapeutics SA Biopôle Route de la Corniche 3B 1066 Epalinges Switzerland Re:ADC Therapeutics SA Registration Statement on Form S-3 Filed March 10, 2026 File No. 333-294191 Dear Ameet Mallik: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Daniel Crawford at 202-551-7767 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Yasin Keshvargar, Esq.
Show Raw Text
March 12, 2026
Ameet Mallik
Chief Executive Officer and Director
ADC Therapeutics SA
Biopôle
Route de la Corniche 3B
1066 Epalinges
Switzerland
Re:ADC Therapeutics SA
Registration Statement on Form S-3
Filed March 10, 2026
File No. 333-294191
Dear Ameet Mallik:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Daniel Crawford at 202-551-7767 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Yasin Keshvargar, Esq.